All stocks today
71229 stocks real-time data.
All stocks today

Stock quotes

Stock market live

Historical stock prices

Stocks market capitalization

Dividend stocks

Stock earnings

Stock revenue

Stock ratings. Where to invest?

iBio, Inc. revenue reports

iBio, Inc. financial reports, iBio, Inc. annual revenue in 2024. When does iBio, Inc. report revenue?
Add to widgets
Added to widgets

iBio, Inc. total revenue, net income and dynamics of changes in US dollar today

The dynamics of net revenue of iBio, Inc. rose. The change amounted to 60 000 $. The dynamics of net revenue is shown in comparison with the previous report. iBio, Inc. net income is now -7 661 000 $. The dynamics of iBio, Inc. net income went up. The change was 468 000 $. The financial schedule of iBio, Inc. consists of three charts of the main financial indicators of the company: total assets, net revenue, net income. The value of "net income" iBio, Inc. on the graph is displayed in blue. A graph of the value of all iBio, Inc. assets is presented in green bars.

Report date Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
and Change (%)
Comparing current quartal report this year to quartal report last year.
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
and Change (%)
Comparing current quartal report this year to quartal report last year.
31/03/2021 765 000 $ +45.16 % ↑ -7 661 000 $ -
31/12/2020 705 000 $ +124.52 % ↑ -8 129 000 $ -
30/09/2020 410 000 $ +279.63 % ↑ -7 533 000 $ -
30/06/2020 1 120 000 $ +40.88 % ↑ -3 538 000 $ -
31/12/2019 314 000 $ - -3 762 000 $ -
30/09/2019 108 000 $ - -4 463 000 $ -
30/06/2019 795 000 $ - -4 503 000 $ -
31/03/2019 527 000 $ - -4 223 000 $ -
31/12/2018 651 000 $ - -4 469 000 $ -
30/09/2018 45 000 $ - -4 398 000 $ -
30/06/2018 91 000 $ - -4 418 000 $ -
31/03/2018 78 000 $ - -3 962 000 $ -
31/12/2017 153 000 $ - -3 899 000 $ -
30/09/2017 122 000 $ - -3 826 000 $ -
30/06/2017 147 000 $ - -4 329 000 $ -
Show:
to

iBio, Inc. financial report charts

Dates of iBio, Inc. finance reports: 30/06/2017, 31/12/2020, 31/03/2021. Dates and dates of financial statements are established by the laws of the country where the company operates. The latest financial report of iBio, Inc. is available online for such a date - 31/03/2021. Gross profit iBio, Inc. is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services. Gross profit iBio, Inc. is 272 000 $

iBio, Inc. quarterly report dates

Cost of revenue iBio, Inc. is the total cost of producing and distributing of products and services of a company. Cost of revenue iBio, Inc. is 493 000 $ Total revenue iBio, Inc. refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods. Total revenue iBio, Inc. is 765 000 $ Operating income iBio, Inc. is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS). Operating income iBio, Inc. is -7 203 000 $

Net income iBio, Inc. is an entity's income minus cost of goods sold, expenses and taxes for an accounting period. Net income iBio, Inc. is -7 661 000 $ Current assets iBio, Inc. is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year. Current assets iBio, Inc. is 107 203 000 $ Total assets iBio, Inc. refers to the total amount of assets owned by a person or entity. Total assets iBio, Inc. is 142 697 000 $

31/03/2021 31/12/2020 30/09/2020 30/06/2020 31/12/2019 30/09/2019 30/06/2019 31/03/2019 31/12/2018 30/09/2018 30/06/2018 31/03/2018 31/12/2017 30/09/2017 30/06/2017
Gross profit
Gross profit is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services.
272 000 $ 705 000 $ 410 000 $ 1 120 000 $ 314 000 $ 108 000 $ 795 000 $ 527 000 $ 651 000 $ 45 000 $ 91 000 $ - - - -
Cost of revenue
Cost of revenue is the total cost of producing and distributing of products and services of a company.
493 000 $ - - - - - - - - - - - - - -
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
765 000 $ 705 000 $ 410 000 $ 1 120 000 $ 314 000 $ 108 000 $ 795 000 $ 527 000 $ 651 000 $ 45 000 $ 91 000 $ 78 000 $ 153 000 $ 122 000 $ 147 000 $
Operating revenue
Operating revenue is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides.
- - - - 314 000 $ 108 000 $ 795 000 $ 527 000 $ 651 000 $ 45 000 $ 91 000 $ 78 000 $ 153 000 $ 122 000 $ 147 000 $
Operating income
Operating income is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS).
-7 203 000 $ -7 545 000 $ -6 924 000 $ -2 929 000 $ -3 155 000 $ -3 855 000 $ -3 874 000 $ -3 770 000 $ -4 015 000 $ -3 950 000 $ -3 946 000 $ -3 493 000 $ -3 427 000 $ -3 361 000 $ -3 859 000 $
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
-7 661 000 $ -8 129 000 $ -7 533 000 $ -3 538 000 $ -3 762 000 $ -4 463 000 $ -4 503 000 $ -4 223 000 $ -4 469 000 $ -4 398 000 $ -4 418 000 $ -3 962 000 $ -3 899 000 $ -3 826 000 $ -4 329 000 $
R&D spending
Research and Development spending - cost of investigative activities to improve existing products and procedures or to lead to the development of new products and procedures.
2 162 000 $ 2 444 000 $ 1 762 000 $ 349 000 $ 888 000 $ 977 000 $ 1 624 000 $ 1 453 000 $ 1 273 000 $ 1 124 000 $ 1 042 000 $ 966 000 $ 993 000 $ 985 000 $ 1 112 000 $
Operating expense
An operating expense is an expenditure that a business incurs as a result of performing its normal business operations.
7 968 000 $ 8 250 000 $ 7 334 000 $ 4 049 000 $ 3 469 000 $ 3 963 000 $ 4 669 000 $ 4 297 000 $ 4 666 000 $ 3 995 000 $ 4 037 000 $ 3 571 000 $ 3 580 000 $ 3 483 000 $ 4 006 000 $
Current assets
Current assets is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year.
107 203 000 $ 110 882 000 $ 84 959 000 $ 61 748 000 $ 4 007 000 $ 2 361 000 $ 4 808 000 $ 9 586 000 $ 13 969 000 $ 16 335 000 $ 16 285 000 $ 3 986 000 $ 7 823 000 $ 6 382 000 $ 8 572 000 $
Total assets
Total assets refers to the total amount of assets owned by a person or entity.
142 697 000 $ 145 406 000 $ 117 254 000 $ 94 189 000 $ 36 384 000 $ 35 164 000 $ 30 586 000 $ 35 674 000 $ 40 303 000 $ 42 896 000 $ 43 083 000 $ 31 034 000 $ 34 840 000 $ 33 433 000 $ 36 010 000 $
Current cash
Current cash - the sum of all of the cash a company has on the date of report.
84 627 000 $ 91 252 000 $ 77 543 000 $ 55 112 000 $ 3 637 000 $ 2 103 000 $ 4 421 000 $ 9 037 000 $ 13 361 000 $ 16 010 000 $ 15 934 000 $ 3 398 000 $ 7 310 000 $ 5 916 000 $ 8 088 000 $
Current debt
Current debt is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital.
- - - - 4 744 000 $ 4 869 000 $ 3 458 000 $ 4 046 000 $ 4 445 000 $ 5 036 000 $ 2 035 000 $ 194 000 $ 190 000 $ 187 000 $ 183 000 $
Total cash
Total cash - the sum of all of the cash a company has on its books, including petty cash and funds on deposit in a bank.
- - - - - - - - - - - 3 398 000 $ 7 310 000 $ 5 916 000 $ 8 088 000 $
Total debt
Total debt is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year.
- - - - 36 904 000 $ 37 104 000 $ 28 129 000 $ 28 772 000 $ 29 225 000 $ 29 868 000 $ 26 919 000 $ 25 129 000 $ 25 175 000 $ 25 221 000 $ 25 265 000 $
Debt ratio
Total debt to total assets - is a financial ratio that indicates the percentage of a company's assets that are provided via debt.
- - - - 101.43 % 105.52 % 91.97 % 80.65 % 72.51 % 69.63 % 62.48 % 80.97 % 72.26 % 75.44 % 70.16 %
Shareholders equity
Shareholder's equity (SE) is the owner's claim after subtracting total liabilities from total assets.
104 845 000 $ 107 335 000 $ 80 054 000 $ 56 618 000 $ -511 000 $ -1 933 000 $ 2 463 000 $ 6 907 000 $ 11 082 000 $ 13 031 000 $ 16 166 000 $ 4 154 000 $ 7 812 000 $ 6 293 000 $ 8 914 000 $
Cash flow
Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business.
- - - - -3 405 000 $ -2 287 000 $ -4 392 000 $ -4 135 000 $ -4 670 000 $ -778 000 $ -3 375 000 $ -3 500 000 $ -3 588 000 $ -3 017 000 $ -3 765 000 $

Last revenue report of iBio, Inc. was 31/03/2021. According to last financial report total revenue in iBio, Inc. was 765 000 US dollar and changed by +45.16% since last year. Net income in iBio, Inc. was -7 661 000 $ in last quartal, net income changes to 0%.

Current cash iBio, Inc. - the sum of all of the cash a company has on the date of report. Current cash iBio, Inc. is 84 627 000 $

iBio, Inc. stocks data

iBio, Inc. financials